BIOCARDIA, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
Cost of Revenue
—
Gross Profit
—
R&D↓-20.3% -$287K
$1M
SG&A↓-2.3% -$21K
$885K
D&A↓-80.0% -$12K
$3K
Operating Income↑+15.3% +$268K
$-1M
EBITDA↓-80.0% -$12K
$3K
Interest Expense
—
Interest Income
—
Other Income/Expense
—
Pretax Income
—
Tax Provision
$0
Net Income↑+14.6% +$254K
$-1M
Gross Margin
—
Operating Margin
-54966.7%
Net Margin
-54866.7%
Effective Tax Rate
—
Deferred Tax Liabilities
$0
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+5.9pts
10.5%
ETR Foreign Differential (pp)↑+0.0pts
0.0%
Operating Lease Cost↑+0.0% +$0
$121K
Revenue YoY Variation↓-7.0pts
-100.0%
Income YoY Variation↓-17.1pts
15.3%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↑+33.9pts
27.5%